PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe - BIT:PHN - IT0005274094 - Common Stock
46.3 EUR
+0.1 (+0.22%)
We assign a fundamental rating of 7 out of 10 to PHN. PHN was compared to 13 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making PHN a very profitable company, without any liquidiy or solvency issues. PHN is valued quite expensively, but it does show have an excellent growth rating. These ratings could make PHN a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
PHN had positive earnings in the past year.
In the past year PHN had a positive cash flow from operations.
PHN had positive earnings in each of the past 5 years.
In the past 5 years PHN always reported a positive cash flow from operatings.
1.2 Ratios
PHN has a better Return On Assets (20.41%) than 100.00% of its industry peers.
PHN's Return On Equity of 38.54% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
The Return On Invested Capital of PHN (26.24%) is better than 100.00% of its industry peers.
PHN had an Average Return On Invested Capital over the past 3 years of 17.21%. This is above the industry average of 12.37%.
The 3 year average ROIC (17.21%) for PHN is below the current ROIC(26.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROIC | 26.24% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
PHN has a Profit Margin of 13.48%. This is in the better half of the industry: PHN outperforms 75.00% of its industry peers.
PHN's Profit Margin has declined in the last couple of years.
PHN's Operating Margin of 21.87% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
PHN's Operating Margin has been stable in the last couple of years.
The Gross Margin of PHN (97.04%) is better than 100.00% of its industry peers.
PHN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
PHN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
The number of shares outstanding for PHN has been reduced compared to 5 years ago.
PHN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 8.68 indicates that PHN is not in any danger for bankruptcy at the moment.
PHN has a better Altman-Z score (8.68) than 100.00% of its industry peers.
The Debt to FCF ratio of PHN is 2.70, which is a good value as it means it would take PHN, 2.70 years of fcf income to pay off all of its debts.
PHN's Debt to FCF ratio of 2.70 is fine compared to the rest of the industry. PHN outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that PHN is not too dependend on debt financing.
The Debt to Equity ratio of PHN (0.28) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Altman-Z | 8.68 |
ROIC/WACC3.32
WACC7.91%
2.3 Liquidity
A Current Ratio of 2.06 indicates that PHN has no problem at all paying its short term obligations.
PHN's Current ratio of 2.06 is amongst the best of the industry. PHN outperforms 91.67% of its industry peers.
PHN has a Quick Ratio of 1.75. This is a normal value and indicates that PHN is financially healthy and should not expect problems in meeting its short term obligations.
PHN has a better Quick ratio (1.75) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
PHN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.20%, which is quite impressive.
The Earnings Per Share has been growing by 14.63% on average over the past years. This is quite good.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 15.06% in the last year.
PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.59% yearly.
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
3.2 Future
The Earnings Per Share is expected to grow by 13.52% on average over the next years. This is quite good.
PHN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.05% yearly.
EPS Next Y8.85%
EPS Next 2Y12.93%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue Next Year14.06%
Revenue Next 2Y14.01%
Revenue Next 3Y13.43%
Revenue Next 5Y12.05%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.90 indicates a rather expensive valuation of PHN.
Based on the Price/Earnings ratio, PHN is valued cheaper than 83.33% of the companies in the same industry.
PHN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
PHN is valuated rather expensively with a Price/Forward Earnings ratio of 19.08.
66.67% of the companies in the same industry are cheaper than PHN, based on the Price/Forward Earnings ratio.
PHN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.55, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.9 | ||
| Fwd PE | 19.08 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHN is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHN indicates a slightly more expensive valuation: PHN is more expensive than 75.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.72 | ||
| EV/EBITDA | 10.53 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PHN has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PHN's earnings are expected to grow with 13.52% in the coming years.
PEG (NY)2.14
PEG (5Y)1.29
EPS Next 2Y12.93%
EPS Next 3Y13.52%
5. Dividend
5.1 Amount
PHN has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
PHN's Dividend Yield is comparable with the industry average which is at 2.54.
Compared to an average S&P500 Dividend Yield of 2.37, PHN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
5.2 History
On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHN pays out 40.63% of its income as dividend. This is a bit on the high side, but may be sustainable.
PHN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP40.63%
EPS Next 2Y12.93%
EPS Next 3Y13.52%
BIT:PHN (10/31/2025, 7:00:00 PM)
46.3
+0.1 (+0.22%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners17.08%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap448.18M
Revenue(TTM)175.08M
Net Income(TTM)23.61M
Analysts83.33
Price Target82.62 (78.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP40.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.53%
PT rev (3m)-1.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.9 | ||
| Fwd PE | 19.08 | ||
| P/S | 2.56 | ||
| P/FCF | 54.72 | ||
| P/OCF | 36.36 | ||
| P/B | 7.32 | ||
| P/tB | 12.01 | ||
| EV/EBITDA | 10.53 |
EPS(TTM)2.45
EY5.29%
EPS(NY)2.43
Fwd EY5.24%
FCF(TTM)0.85
FCFY1.83%
OCF(TTM)1.27
OCFY2.75%
SpS18.09
BVpS6.33
TBVpS3.86
PEG (NY)2.14
PEG (5Y)1.29
Graham Number18.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROCE | 45.24% | ||
| ROIC | 26.24% | ||
| ROICexc | 32.19% | ||
| ROICexgc | 49.25% | ||
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% | ||
| FCFM | 4.68% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexgc growth 3Y-15.98%
ROICexgc growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | 97.13% | ||
| Cap/Sales | 2.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.97% | ||
| Profit Quality | 34.7% | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 8.68 |
F-Score7
WACC7.91%
ROIC/WACC3.32
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
EPS Next Y8.85%
EPS Next 2Y12.93%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
Revenue Next Year14.06%
Revenue Next 2Y14.01%
Revenue Next 3Y13.43%
Revenue Next 5Y12.05%
EBIT growth 1Y14.83%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year22.06%
EBIT Next 3Y16.37%
EBIT Next 5Y9.96%
FCF growth 1Y144.25%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y38.33%
OCF growth 3Y0.14%
OCF growth 5Y11.34%
PHARMANUTRA SPA / PHN.MI FAQ
What is the fundamental rating for PHN stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI.
What is the valuation status for PHN stock?
ChartMill assigns a valuation rating of 3 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Overvalued.
How profitable is PHARMANUTRA SPA (PHN.MI) stock?
PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.
Can you provide the financial health for PHN stock?
The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.
How sustainable is the dividend of PHARMANUTRA SPA (PHN.MI) stock?
The dividend rating of PHARMANUTRA SPA (PHN.MI) is 5 / 10 and the dividend payout ratio is 40.63%.